Synthetic biology drugs
Synthetic biology uses the organisms to manufacture the targeted drugs by recombining artificial biosynthetic pathways in the host. Some of the drugs produced by this application are vancomycine, cyclosporine. Synthetic biology is the engineering of biology: the synthesis of complex, biologically based (or inspired) systems which display functions that do not exist in nature. Synthetic biologists use polypeptides for the manufacturing of desired drugs assembling all together into a single complex. This engineering perspective may be applied at all levels of the hierarchy of biological structures – from individual molecules to whole cells, tissues and organisms.
- Drug Therapy
- Drug Metabolism
- Cytogenetics
- Chemical Biology of Molecules
- Bioactive Compounds
- Natural Medicine
Related Conference of Synthetic biology drugs
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Synthetic biology drugs Conference Speakers
Recommended Sessions
- Applications of Synthetic Biology
- Bio-Sensors and Bio-Electronics
- Biology Engineering
- Biophysics
- Cancer systems biology
- Cellular Systems Biology
- Cellular Systems Biology
- Computational Systems Biology
- CRISPR-Cas9 Genome Editing
- Gene synthesis
- Industrial Systems and Synthetic Biology
- Integrative Biology
- Mammalian Synthetic Biology
- Metabolomics
- Next Generation Sequencing
- Pharmaceutical Biology
- Plant Synthetic Biology
- Protein Engineering
- Synthetic Biology Business
- Synthetic biology drugs
- Synthetic Chemistry
- Synthetic Engineering
- Synthetic Gene Networks
- Synthetic Genomics
- Synthetic Technology
- Systems and Synthetic Biology
- Systems Biology
- Systems Biology
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)